DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 158 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $34,947,528 | -6.4% | 2,704,917 | -28.9% | 1.36% | -17.7% |
| Q1 2023 | $37,330,680 | -7.8% | 3,805,370 | 0.0% | 1.65% | +13.7% |
| Q4 2022 | $40,489,137 | +1.9% | 3,805,370 | 0.0% | 1.45% | +0.9% |
| Q3 2022 | $39,728,000 | -17.1% | 3,805,370 | 0.0% | 1.44% | -21.4% |
| Q2 2022 | $47,910,000 | +16.1% | 3,805,370 | 0.0% | 1.83% | +18.5% |
| Q1 2022 | $41,250,000 | -23.0% | 3,805,370 | 0.0% | 1.54% | -15.4% |
| Q4 2021 | $53,542,000 | -15.1% | 3,805,370 | +15.9% | 1.82% | -1.7% |
| Q3 2021 | $63,077,000 | +114.1% | 3,283,570 | +9.8% | 1.86% | +101.0% |
| Q2 2021 | $29,459,000 | -14.1% | 2,990,770 | -14.3% | 0.92% | -11.9% |
| Q1 2021 | $34,314,000 | +162.5% | 3,490,770 | +18.9% | 1.05% | +127.8% |
| Q4 2020 | $13,070,000 | +3.0% | 2,936,990 | 0.0% | 0.46% | -21.6% |
| Q3 2020 | $12,688,000 | +25.1% | 2,936,990 | +156.8% | 0.59% | +11.6% |
| Q2 2020 | $10,143,000 | – | 1,143,526 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
| Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
| Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
| Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
| Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
| Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
| AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
| HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
| Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
| Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |